Targeting c-MYC in Platinum-Resistant Ovarian Cancer.

Reyes-Gonz?lez JM, Armaiz-Pe?a GN, Mangala LS, Valiyeva F, Ivan C, Pradeep S, Echevarr?a-Vargas IM, Rivera-Reyes A, Sood AK, Vivas-Mej?a PE. Targeting c-MYC in Platinum-Resistant Ovarian Cancer. Mol Cancer Ther. 2015 Oct; 14(10):2260-9.

View in: PubMed

subject areas

Animals
Antineoplastic Agents
Apoptosis
Cell Line, Tumor
Cell Survival
Cisplatin
Disease-Free Survival
Drug Resistance, Neoplasm
Female
Gene Expression
Gene Knockdown Techniques
Humans
Mice, Nude
Ovarian Neoplasms
Proto-Oncogene Proteins c-myc
RNA, Small Interfering
Xenograft Model Antitumor Assays

authors with profiles

Pablo Vivas
Guillermo N Armaiz Pena

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support